MedDataX Logo

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

NCT ID: NCT06169592

Last Updated: 2025-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-22

Study Completion Date

2026-12-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Cirrhosis Liver Transplant; Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

liver transplant group

Liver transplantation

Intervention Type PROCEDURE

Related transplantation of the right lobe of the liver

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liver transplantation

Related transplantation of the right lobe of the liver

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age over 18 years and up to 70 years;
* Signed informed consent for inclusion to the study;
* End stage liver cirrhosis.

Exclusion Criteria

* Pregnancy;
* Extrahepatic factors influencing systemic hemostasis;
* Concomitant hematological diseases affecting the hemostatic system;
* Severe concomitant disorders.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Azam Babadjanov

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov

Tashkent, , Uzbekistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Uzbekistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Azam Babadjanov, Professor

Role: CONTACT

Phone: +998901751703

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Azam Babadjanov, Professor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05122023

Identifier Type: -

Identifier Source: org_study_id